Insurer Exits After the Inflation Reduction Act Part D Redesign.
作者信息
Cai Christopher L, Kesselheim Aaron S, Bhaskar Anushka, Rome Benjamin N
机构信息
Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.
出版信息
JAMA. 2025 Jul 22;334(4):360-362. doi: 10.1001/jama.2025.7289.
Abstract
摘要
相似文献
1
Insurer Exits After the Inflation Reduction Act Part D Redesign.《降低通胀法案》D 部分重新设计后保险公司退出。
JAMA. 2025 Jul 22;334(4):360-362. doi: 10.1001/jama.2025.7289.
2
Changes in Out-of-Pocket Drug Expenditures Among Medicare Beneficiaries With Dementia Under the Inflation Reduction Act: A Simulation Study.《降低通胀法案》下患有痴呆症的医疗保险受益人的自付药品费用变化：一项模拟研究
Value Health. 2025 Apr;28(4):553-561. doi: 10.1016/j.jval.2025.01.008. Epub 2025 Jan 27.
3
Estimated True Out-of-Pocket Cost Changes of the Inflation Reduction Act on Medicare Part D Beneficiaries with Cancer.《降低通胀法案》对患有癌症的医疗保险D部分受益人的估计真实自付费用变化
Value Health. 2025 Jul 15. doi: 10.1016/j.jval.2025.07.003.
4
Out-of-Pocket Prescription Drug Savings for Medicare Beneficiaries with Asthma and COPD Under the Inflation Reduction Act.《降低通胀法案》下哮喘和慢性阻塞性肺疾病医疗保险受益人的自付处方药节省费用情况
J Gen Intern Med. 2025 Apr;40(5):1141-1149. doi: 10.1007/s11606-024-09063-4. Epub 2024 Oct 4.
5
Share of Sales Subject to Medicare Inflation Rebates and Price Increases of Top-Selling Drugs.受医疗保险通胀回扣和畅销药品价格上涨影响的销售额占比。
Health Serv Res. 2025 Jul 14:e70012. doi: 10.1111/1475-6773.70012.
6
Social Determinants of Health and US Health Care Expenditures by Insurer.社会决定因素与美国不同保险机构的医疗保健支出。
JAMA Netw Open. 2024 Oct 1;7(10):e2440467. doi: 10.1001/jamanetworkopen.2024.40467.
7
Patient-Reported Characteristics Across Dual-Eligible Medicare Advantage Plan Types.双重资格医疗保险优势计划类型的患者报告特征。
JAMA Netw Open. 2025 Apr 1;8(4):e255791. doi: 10.1001/jamanetworkopen.2025.5791.
8
Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.评估主要医疗保险优势计划和传统医疗保险中的低价值服务。
JAMA Netw Open. 2024 Nov 4;7(11):e2442633. doi: 10.1001/jamanetworkopen.2024.42633.
9
Private Medicare plans' responses to benchmark changes and competition before and after the Affordable Care Act's payment cuts.《平价医疗法案》支付削减前后，私人医疗保险计划对基准变化及竞争的应对措施。
Health Serv Res. 2025 Apr;60(2):e14392. doi: 10.1111/1475-6773.14392. Epub 2024 Oct 21.
10
Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Risk Factors Under the Inflation Reduction Act.《平价医疗法案下，心血管疾病风险因素的 Medicare 受益人自付药品费用》。
J Am Coll Cardiol. 2023 Apr 18;81(15):1491-1501. doi: 10.1016/j.jacc.2023.02.002. Epub 2023 Feb 20.
引用本文的文献
1
Changes in Medicare Part D Plan Designs After the Inflation Reduction Act.《降低通胀法案》出台后医疗保险D部分计划设计的变化。
JAMA Intern Med. 2025 Aug 18. doi: 10.1001/jamainternmed.2025.4003.
本文引用的文献
1
Improving the Affordability of Prescription Drugs for Medicare Beneficiaries.提高医疗保险受益人的处方药可负担性。
JAMA Intern Med. 2025 Mar 1;185(3):260-261. doi: 10.1001/jamainternmed.2024.6915.
2
Association of Insurance Gains and Losses With Access to Prescription Drugs.保险损益与获取处方药物的关联性。
JAMA Intern Med. 2017 Oct 1;177(10):1531-1532. doi: 10.1001/jamainternmed.2017.4011.
Zotero 插件